https://www.marketscreener.com/quote/stock/OLEMA-PHARMACEUTICALS-INC-115395186/news/Olema-Pharmaceuticals-Inc-Nominates-OP-3136-an-Orally-Bioavailable-KAT6-Inhibitor-as-a-Developme-45694731/?utm_source=telegram&utm_medium=social&utm_campaign=share